Sugammadex and Cognitive Function

Post Operative Cognitive Dysfunction Clinical Trial

Official title:
Effect of Sugammadex Versus Neostigmine/Atropine Combination on Cognitive Function After Elective Adult Surgery

Status Completed

Clinical Trial Summary

Post operative cognitive dysfunction (POCD) is recognized as a frequent complication after both cardiac and non cardiac surgery, affecting approximately 1/3 of the patients. The aim of this study is to examine the possible effect of the novel reversal agent sugammadex versus neostigmine/ atropine combination on cognitive function of adult patients after elective surgery during the early post operative period as well as at discharge.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cognitive Dysfunction
Post Operative Cognitive Dysfunction

Clinical Trial Details

NCT number	NCT02419352
Study type	Interventional
Source	Attikon Hospital
Contact
Status	Completed
Phase	N/A
Start date	September 2010
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00507663` - Elder Surgery - Functional Recovery Following Beta Blockade	Phase 4
Completed	`NCT02051452` - Reversal of General Anesthesia With Methylphenidate	Phase 1/Phase 2
Completed	`NCT01993836` - Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care	Phase 4
Completed	`NCT03290599` - Effect of Preoperative Hospitalization Duration on Post-operative Cognitive Dysfunction	N/A
Completed	`NCT02892916` - Ketamine and Postoperative Cognitive Dysfunction	Phase 3
Completed	`NCT04267328` - Post-Operative Cognitive Dysfunction in Normal Aging Patients Undergoing Elective Orthopedic Surgery
Terminated	`NCT03485404` - Preoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical Patients	N/A